Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C.

Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C. Abstract Text:

    joonho yoonJoonho Yoon,jong-in leeJong-In Lee,soon-koo baikSoon-Koo Baik,kwang-ho leeKwang-Ho Lee,joon-hyung sohnJoon-Hyung Sohn,hyean-woo leeHyean-Woo Lee,jun namkungJun Namkung,sei-jin changSei-Jin Chang,jong-whan choiJong-Whan Choi,hyun-won kimHyun-Won Kim,byung-il yehByung-Il Yeh,joonho yoonJoonho Yoon,jong in leeJong In Lee,soon koo baikSoon Koo Baik,kwang ho leeKwang Ho Lee,joon hyung sohnJoon Hyung Sohn,hyean woo leeHyean Woo Lee,jun namkungJun Namkung,sei jin changSei Jin Chang,jong whan choiJong Whan Choi,hyun won kimHyun Won Kim,byung-il yehByung-Il Yeh,

    AIM: To confirm the predictive factors for interferon (IFN)-alpha and ribavirin combination therapy for chronic hepatitis patients with hepatitis C virus (HCV) genotype 1b. METHODS: HCV RNA from 50 patients infected with HCV genotype 1b was studied by cloning and sequencing of interferon sensitivity determining region (ISDR), PKR-eIF2alpha phosphorylation homology domain (PePHD). Patients were treated with IFN-alpha and ribavirin for 6 mo and grouped by effectiveness of the therapy. A variety of factors were analyzed. RESULTS: Our data showed that age, HCV RNA titer, and ISDR type could be used as the predictive factors for combined IFN-alpha and ribavirin efficacy. Characteristically, mutations in PePHD appeared only when the combination therapy was effective. Other factors, such as sex and alanine aminotransferase (ALT) level, were not related to its efficacy. Adjusting for age and HCV RNA titer indicated that the ISDR type was the most potent predictive factor. CONCLUSION: HCV RNA ISDR type is an important factor for predicting efficacy of IFN-alpha and ribavirin combination therapy in Korean patients.

    Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C. Publishing Authors By Initials

    j yoonJ Yoon,ji leeJI Lee,sk baikSK Baik,kh leeKH Lee,jh sohnJH Sohn,hw leeHW Lee,j namkungJ Namkung,sj changSJ Chang,jw choiJW Choi,hw kimHW Kim,bi yehBI Yeh,j yoonJ Yoon,ji leeJI Lee,sk baikSK Baik,kh leeKH Lee,jh sohnJH Sohn,hw leeHW Lee,j namkungJ Namkung,sj changSJ Chang,jw choiJW Choi,hw kimHW Kim,bi yehBI Yeh,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: World journal of gastroenterology : WJG

    VOLUME: 13

    Page Numbers: 6236-42

    Journal Abbreviation: World J. Gastroenterol.

    ISSN: 1007-9327

    DAY: 14

    MONTH: Dec

    YEAR: 2007

    Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100883448

    Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C.

    AFFILIATION: Department of Biochemistry, Wonju College of Medicine, Yonsei University, 162 Ilsandong, Wonju, Gangwondo 220-701, Republic of Korea. biyeh64@hotmail.com.

    Country: China

    China Research PublicationChina Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: World J Gastroenterol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News